Is Premorbid Functioning a Predictor of Outcome in Patients With Early Onset Psychosis Treated With Risperdal Consta?
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2009
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen
- 06 Oct 2009 Actual end date (Nov 2007) and actual number of patients (303) added as reported by ClinicalTrials.gov.
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.